Institutional investors hold a majority ownership of A through the 85.85% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended January 2015, these large investors purchased a net $202.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEGROOF FUND MANAGEMENT COMPANY ... Bought 88.0 Thousand shares of Agilent Technologies Inc
SIVIK GLOBAL HEALTHCARE LLC Bought 70.0 Thousand shares of Agilent Technologies Inc